SNNC
Sibannac, Inc.0.0180
-0.0010-5.26%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
2.44MP/E (TTM)
-Basic EPS (TTM)
-0.05Dividend Yield
0%Recent Filings
8-K
Licensing Copper 1 patents
Sibannac entered a memorandum of understanding on July 15, 2020, advancing negotiations for a licensing agreement with C LAB PHARMA, SA/MitoSynergy to access U.S. patents on bioavailable Copper 1 compounds, backed by an FDA No Objection Letter for new dietary ingredient status. The deal targets development and sales of YourCopper-branded nutraceutical products combining Copper 1 and CBD to boost immune support, energy, pain relief, and focus in the $400 billion market. Yet risks linger in finalizing the agreement. Forward-looking statements highlight inherent uncertainties.
8-K
FDA registration unlocks CBD production
Sibannac secured an FDA registration number on July 13, 2020, to operate a food facility for manufacturing CBD ingestibles and formulations with B17 and apricot seeds under its brands. To meet cGMP standards, the company hired a consultant for essential processes and is negotiating custom CBD products with rare ingredients. CEO David Mersky swapped 43,872,806 common shares from the 2017 acquisition for Preferred Class B stock, leaving 16,127,104 common shares outstanding, including just 1,015,000 free-trading. This positions Sibannac for compliant consumer market entry. Forward-looking statements highlight inherent risks.
8-K
Sibannac's dual asset pursuits
Sibannac announced an asset purchase agreement to acquire NOHO's intellectual property, using newly issued securities as consideration in a structured exchange that swaps free-trading NOHO shares for Sibannac shares, with completion targeted for Fall 2020 pending audits and approvals. This bolsters Sibannac's hangover remedy lineup by integrating the NOHO brand with CBD formulations from its Scottsdale facility. Separately, Sibannac advances toward controlling interest in Richardson Nutritional Center, securing U.S. apricot seed offtake contracts to expand in natural health amid CBD regulatory flux. Operations now run from Arizona.
8-K
Sibannac's acquisition MOU and board refresh
Sibannac entered a non-binding MOU on May 18, 2020, to acquire 51% of a 20-year-old apricot seed processing firm with exclusive U.S. domestic offtake rights via a third-party farming group, targeting Vitamin B-17-rich products. The company bolstered governance by appointing finance veteran James D. Staudohar as Audit Committee chair and trial attorney Booker T. Evans, Jr. to its board, while engaging Semple, Marchal & Cooper as auditors for Q3 completion. It also amended articles to designate Preferred A and B shares and rollback common shares to 60 million. Current outstanding shares stand at 16,127,194.
8-K
Alliance terminated, domestic pivot
Sibannac terminated its Strategic Alliance Agreement with Bravatek Solutions on December 13, 2017, after limited engagement, shifting focus to domestic sales in the US and Canada for better manufacturing and logistics proximity. This move shelves Asian and European expansion timelines, eliminating the need for regional marketing partners. Negotiations continue for an equity acquisition of Global Air Cylinder Wheel, with advanced talks for lab and on-site testing with mining firms. No international push now.
IPO
Website
Employees
Sector
Industry
ACB
Aurora Cannabis Inc.
5.53+0.41
BUDZ
WEED, Inc.
0.06+0.01
CBDL
CBD Life Sciences Inc.
0.00+0.00
CBSTF
THE CANNABIST COMPANY HOLDINGS
0.10+0.03
CPMD
Cannapharmarx Inc.
0.00-0.00
GCAN
Greater Cannabis Co Inc.
0.08+0.00
HSTI
High Sierra Technologies Inc.
1.40+0.00
LVRLF
CordovaCann Corp.
0.03+0.00
PNXP
Pineapple Express Cannabis Comp
0.01+0.00
SKYI
Sky Century Investment, Inc.
0.00+0.00